248 related articles for article (PubMed ID: 16795934)
1. Medical devices; exception from general requirements for informed consent. Interim final rule.
Food and Drug Administration, HHS
Fed Regist; 2006 Jun; 71(109):32827-34. PubMed ID: 16795934
[TBL] [Abstract][Full Text] [Related]
2. Medical devices; exception from general requirements for informed consent. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2011 Jun; 76(122):36989-93. PubMed ID: 21736160
[TBL] [Abstract][Full Text] [Related]
3. Human drugs and biologics; determination that informed consent is NOT feasible or is contrary to the best interests of recipients; revocation of 1990 interim final rule; establishment of new interim final rule. Food and Drug Administration, HHS. Interim final rule; opportunity for public comment.
Fed Regist; 1999 Oct; 64(192):54180-9. PubMed ID: 11010702
[TBL] [Abstract][Full Text] [Related]
4. Investigational new drug application; exception from informed consent; technical amendment--FDA. Final rule.
Fed Regist; 1997 Jun; 62(115):32479. PubMed ID: 10169828
[TBL] [Abstract][Full Text] [Related]
5. Protection of human subjects; informed consent--FDA. Final rule.
Fed Regist; 1996 Oct; 61(192):51498-533. PubMed ID: 10161558
[TBL] [Abstract][Full Text] [Related]
6. Exceptions or alternatives to labeling requirements for products held by the Strategic National Stockpile. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2012 Feb; 77(24):5696-9. PubMed ID: 22359804
[TBL] [Abstract][Full Text] [Related]
7. Medical devices; procedures for investigational device exemptions--Food and Drug Administration. Final rule.
Fed Regist; 1980 Jan; 45(13):3732-59. PubMed ID: 10248822
[TBL] [Abstract][Full Text] [Related]
8. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
Fed Regist; 1994 Jun; 59(116):31138. PubMed ID: 10136908
[TBL] [Abstract][Full Text] [Related]
9. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
[TBL] [Abstract][Full Text] [Related]
10. Accessibility to new drugs for use in military and civilian exigencies when traditional human efficacy studies are not feasible; determination under the interim rule that informed consent is not feasible for military exigencies; request for comments--FDA. Request for comments.
Fed Regist; 1997 Jul; 62(147):40996-1001. PubMed ID: 10169831
[TBL] [Abstract][Full Text] [Related]
11. Expanded access to investigational drugs for treatment use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
[TBL] [Abstract][Full Text] [Related]
12. Protection of human subjects; informed consent--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(17 pt 2):8942-58. PubMed ID: 10249528
[TBL] [Abstract][Full Text] [Related]
13. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Proposed rule.
Fed Regist; 1988 Nov; 53(218):45678-82. PubMed ID: 10290533
[TBL] [Abstract][Full Text] [Related]
14. Office of the Assistant Secretary for Preparedness and Response; HHS Public Health Emergency Medical Countermeasures Enterprise implementation plan for chemical, biological, radiological and nuclear threats. Notice.
Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services
Fed Regist; 2007 Apr; 72(77):20117-28. PubMed ID: 17520758
[TBL] [Abstract][Full Text] [Related]
15. Medical device reporting--FDA. Final rule.
Fed Regist; 1984 Sep; 49(180):36326-51. PubMed ID: 10267669
[TBL] [Abstract][Full Text] [Related]
16. Obstetric and gynecology devices; effective date of requirement for premarket approval for glans sheath devices. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Jun; 67(115):40848-9. PubMed ID: 12068899
[TBL] [Abstract][Full Text] [Related]
17. FDA, off-label use, and informed consent: debunking myths and misconceptions.
Beck JM; Azari ED
Food Drug Law J; 1998; 53(1):71-104. PubMed ID: 11795338
[No Abstract] [Full Text] [Related]
18. Orthopedic devices; effective data of requirement for premarket approval for hip joint metal/polymer or ceramic/polymer semiconstrained resurfacing cemented prosthesis. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Oct; 69(191):59132-4. PubMed ID: 15460583
[TBL] [Abstract][Full Text] [Related]
19. Medical devices; effective date of requirement for premarket approval for three preamendment class III devices. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Apr; 65(72):19833-4. PubMed ID: 11010634
[TBL] [Abstract][Full Text] [Related]
20. Medical devices; obstetrical and gynecological devices; classification of the breast lesion documentation system. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jul; 68(144):44413-5. PubMed ID: 12884877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
